DRT, a plant chemistry company of the Firmenich Group, confirms the initial announcement to invest in a large-scale, state-of-the-art plant to manufacture hydrogenated rosin and resin derivatives.
DRT laid out a plan to invest in a new production unit for highly hydrogenated rosin. The company has announce that the large-scale facility is expected to be completed during the third quarter of 2022.
Boosting Global Supply
The new plant, of which construction was initially delayed due to the COVID-19 pandemic, will place DRT in a strategic position to address the anticipated growth in key industry segments. It will also strengthen the Company’s global supply capabilities.
Located in Vielle Saint-Girons, France, the project also includes a hydrogenation pilot plant that has already been commissioned and is now fully operational. The new production unit will allow DRT to supply products with the highest degree of hydrogenation.
This investment will position DRT as a supplier of hydrogenated rosin and resin derivatives, with dual production capabilities in Europe and the U.S. This additional capacity will enable DRT to meet the growing demand for sustainable raw materials in a variety of industry segments, such as adhesives, tires, coating and construction, elastomers & plastics modification, agriculture and energy.
Source: Afera